In vivo PET imaging and postmortem studies suggest potentially reversible and irreversible stages of brain metabolic failure in Alzheimer's disease

European Archives of Psychiatry and Clinical Neuroscience

Volumn 249, Issue SUPPL. 3, 1999, Pages

  Rapoport, Stanley I ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Activation; Alzheimer's disease; Blood flow; Brain; Cytochrome oxidase; Energy; Glucose; Metabolism; Mitochondria; Oxidative phosphorylation; Positron emission tomography

Indexed keywords

ALZHEIMER DISEASE; AUTOPSY; BRAIN BLOOD FLOW; BRAIN METABOLISM; COGNITION; CONFERENCE PAPER; DISEASE SEVERITY; GLUCOSE BRAIN LEVEL; GLUCOSE METABOLISM; HUMAN; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

EID: 0342980328     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/pl00014174     Document Type: Conference Paper

References (70)

1. Azari NP, Pettigrew KD, Schapiro MB, Haxby JV, Grady CL, Pietrini P, Salerno JA, Heston LL, Rapoport SI, Horwitz B (1993) Early detection of Alzheimer's disease: A statistical approach using positron emission tomographic data. J Cereb Blood Flow Metab 13:438-447
2. Benton A (1985). Visuoperceptual, visuospatial, and visuoconstructive disorders. In: Heilman KM ,Valenstein E (eds) Clinical Neuropsychology. 2nd ed Oxford University Press, New York, pp 151-185
3. Braak H, Braak E, Bohl J (1993) Staging of Alzheimer-related cortical destruction. Eur Neurol 33:403-408
4. Chandrasekaran K, Giordano T, Brady DR, Stoll J, Martin LJ, Rapoport SI (1994) Impairment of mitochondrial cytochrome oxidase gene expression in Alzheimer's disease. Brain Res Mol Brain Res 24 (S-1):336-340
5. Chandrasekaran K, Hatanpää K, Brady DR, Rapoport SI (1996) Evidence for physiological down-regulation of brain oxidative phosphorylation in Alzheimer's disease. Exp Neurol 142:80-88
6. Chandrasekaran K, Hatanpää K, Rapoport SI, Brady DR (1997) Decreased expression of nuclear and mitochondrial DNA-encoded genes of oxidative phosphorylation in association neocortex of Alzheimer's disease. Brain Res Mol Brain Res 44: 99-104
7. Chandrasekaran K, Stoll J, Brady DR, Rapoport SI (1992) Localization of cytochrome oxidase (COX) activity and COX mRNA in the hippocampus and entorhinal cortex in the monkey brain: correlation with specific neuronal pathways. Brain Res 579:333-336
8. Chandrasekaran K, Stoll J, Rapoport SI, Brady DR (1993) Localization of cytochrome oxidase (COX) activity and COX mRNA in the perirhinal and superior temporal sulci of the monkey brain. Brain Res 606:213-219
9. Chauhan NB, Lee JM, Siegel GJ (1997) Na,K-ATPase mRNA levels and plaque load in Alzheimer's disease. J Mol Neurosci 9: 151-156
10. Clark CM, Ammann W, Martin WR, Ty P, Hayden MR (1991) The FDG/PET methodology for early detection of disease onset: A statistical model. J Cereb Blood Flow Metab 11:A96-A 102
11. DeCarli CS, Atack JR, Ball MJ, Kaye JA, Grady CL, Fewster P, Pettigrew KD, Rapoport SI, Schapiro MB (1992) Post-mortem regional neurofibrillary tangle densities but not senile plaque densities are related to regional cerebral metabolic rates for glucose during life in Alzheimer's disease patients. Neurodegeneration 1:113-121
12. DeKosky ST, Scheff SW (1990) Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity. Ann Neurol 27:457-464
13. Folstein MF, Folstein SE, McHugh PR (1975) Mini Mental State. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198
14. Fox PT, Raichle ME (1985) Stimulus rate determines regional brain blood flow in striate cortex. Ann Neurol 17:303-305
15. Fukuyama R, Hatanpää K, Rapoport SI, Chandrasekaran K (1996) Gene expression of ND4, a subunit of complex I of oxidative phosphorylation in mitochondria, is decreased in temporal cortex of brains of Alzheimer's disease patients. Brain Res 713: 290-293
16. Gibson GE, Zhang H, Sheu KF-R, Bogdanovich N, Lindsay JG, Lannfelt L, Vestling M, Cowburn RF (1998) α-Ketoglutarate dehydrogenase in Alzheimer brains bearing the APP670/671 mutation. Ann Neurol 44:676-681
17. Grady CL, Haxby JV, Horwitz B, Gillette J, Salerno JA, Gonzalez-Aviles A, Ungerleider LE, Carson RE, Herscovitch P, Schapiro MB, Rapoport SI (1993) Activation of cerebral blood flow during a visuoperceptual task in patients with Alzheimer-type dementia. Neurobiol Aging 14:35-44
18. Grady CL, Haxby JV, Horwitz B, Sundaram M, Berg G, Schapiro M, Friedland RP, Rapoport SI (1988) Longitudinal study of the early neuropsychological and cerebral metabolic changes in dementia of the Alzheimer type. J Clin Exp Neuropsychol 10: 576-596
19. Grady CL, Haxby JV, Schapiro MB, Gonzalez-Aviles A, Kumar A, Ball MJ, Heston L, Rapoport SI (1990) Subgroups in dementia of the Alzheimer type identified using positron emission tomography. J Neuropsychiatry Clin Neurosci 2:373-384
20. Grady CL, Sonies B, Haxby J, Luxenberg J, Friedland R, Rapoport S (1988) Cerebral metabolic asymmetries predict decline in language performance in dementia of the Alzheimer type (DAT). J Clin Exp Neuropsychol 10:39
21. Harik SI, Mitchell MJ, Kalaria RN (1989) Ouabain binding in the human brain. Effects of Alzheimer's disease and agina. Arch Neurol 46:951-954
22. Hatanpää K, Brady DR, Stoll J, Rapoport SI, Chandrasekaran K (1996) Neuronal activity and early neurofibrillary tangles in Alzheimer's disease. Ann Neurol 40:411-420
23. Hatanpää K, Chandrasekaran K, Brady D, Rapoport SI (1998) No association between Alzheimer plaques and decreased levels of cytochrome oxidase subunit mRNA, a marker of neuronal energy metabolism. Brain Res Mol Brain Res 59:13-21
24. Hatanpää K, Isaacs KR, Shirao T, Brady DR, Rapoport SI (1999) Loss of proteins regulating synaptic plasticity in normal aging of the human brain and in Alzheimer's disease. J Neuropathol Exp Neurol 58:637-643
25. Haxby JV, Grady CL, Duara R, Schlageter N, Berg G, Rapoport SI (1986) Neocortical metabolic abnormalities precede nonmemory cognitive deficits in early Alzheimer's-type dementia. Arch Neurol 43:882-885
26. Haxby JV, Grady CL, Koss E, Horwitz B, Heston L, Schapiro M, Friedland RP, Rapoport SI (1990) Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer type. Arch Neurol 47:753-760
27. Haxby JV, Grady CL, Koss E, Horwitz B, Schapiro M, Friedland RP, Rapoport SI (1988) Heterogeneous anterior-posterior metabolic patterns in dementia of the Alzheimer type. Neurology 38: 1853-1863
28. Haxby JV, Raffaele K, Gillette J, Schapiro MB, Rapoport SI (1992) Individual trajectories of cognitive decline in patients with dementia of the Alzheimer type. J Clin Exp Neuropsychol 14:575-592
29. Heddi A, Lestienne P, Wallace DC, Stepien G (1993) Mitochondrial DNA expression in mitochondrial myopathies and coordinated expression of nuclear genes involved in ATP production. J Biol Chem 268:12156-12163
30. +-ATPase. Neurosci Lett 138 :188-192
31. Hevner RF, Wong-Riley MTT (1991) Neuronal expression of nuclear and mitochondrial genes for cytochrome oxidase (CO) subunits analyzed by in situ hybridization: comparison with CO activity and protein. J Neurosci 11:1942-1958
32. Hevner RF, Wong-Riley MTT (1993) Mitochondrial and nuclear gene expression for cytochrome oxidase subunits are disproportionately regulated by functional activity in neurons. J Neurosci 13:1805-1819
33. Horwitz B, Grady CL, Schlageter NL, Duara R, Rapoport SI (1987) Intercorrelations of regional cerebral glucose metabolic rates in Alzheimer's disease. Brain Res 407:294-306
34. Ibáñez V, Pietrini P, Alexander GE, Furey ML, Teichberg D, Rajapakse JC, Rapoport SI, Schapiro MB, Horwitz B (1998) Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease. Neurology 50:1585-1593
35. Kalaria RN, Harik SI (1989) Reduced glucose transporter at the blood-brain barrier and in cerebral cortex in Alzheimer's disease. J Neurochem 53:1083-1088
36. Kennedy AM, Frackowiak RSJ, Newman SK, Bloomfield PM, Seaward J, Roques P, Lewington G, Cunningham VJ, Rossor MN (1995) Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer's disease. Neurosci Lett 186:17-20
37. Kumar A, Schapiro MB, Grady C, Haxby JV, Wagner E, Salerno JA, Friedland RP, Rapoport SI (1991) High-resolution PET studies in Alzheimer's disease. Neuropsychopharmacology 4: 35-46
38. Lehninger AL, Nelson DL, Cox MM (1993) Principles of Biochemistry. 2nd ed Worth Press, New York, pp 1013
39. Lewis DA, Campbell MJ, Terry RD, Morrison JH (1987) Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: A quantitative study of visual and auditory cortices. J Neurosci 7:1799-1808
40. Liu S, Wong-Riley M (1994) Nuclear-encoded mitochondrial precursor protein: intramitochondrial delivery to dendrites and axon terminals of neurons and regulation of neuronal activity. J Neurosci 14:5338-5351
41. Livingstone M, Hubel D (1988) Segregation of form, color, movement, and depth: anatomy, physiology, and perception. Science 240:740-749
42. Löw G (1998) Personal communication. Director Eisai-Pfizer, Germany
43. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services task force on Alzheimer's disease. Neurology 34:939-944
44. Mentis MJ, Alexander GE, Grady CL, Horwitz B, Krasuski J, Pietrini P, Strassburger T, Hampel H, Schapiro MB, Rapoport SI (1997) Frequency variation of a pattern-flash visual stimulus during PET differentially activates brain from striate through frontal cortex. Neuroimage 5:116-128
45. Mentis MJ, Alexander GE, Krasuski J, Pietrini P, Furey ML, Schapiro MB. Rapoport SI (1998) Increasing required neural response to expose abnormal brain function in mild versus moderate or severe Alzheimer's disease: PET study using parametric visual stimulation. Am J Psychiatry 155:785-794
46. Mentis MJ, Horwitz B, Grady CL, Alexander GE, VanMeter JW, Maisog JM, Pietrini P, Schapiro MB, Rapoport SI (1996) Visual cortical dysfunction in Alzheimer's disease evaluated with a temporally graded "stress test" during PET. Am J Psychiatry 153:32-40
47. Morrison JH, Hof PR, Campbell MJ, DeLima AD, Voigt T, Bouras C, Cox K, Young WG (1990). Cellular pathology in Alzheimer's disease: implications for corticocortical disconnection and differential vulnerability. In: Rapoport SI, Petit H, Leys D, Christen Y (eds) Imaging, Cerebral Topography and Alzheimer's Disease. Research and Perspectives in Alzheimer's diseas. Springer-Verlag. Fondation Ipsen, Berlin pp 19-40
48. Parker Jr WD, Parks J, Filley CM, Kleinschmidt-DeMasters BK (1994) Electron transport chain defects in Alzheimer's disease brain. Neurology 44:1090-1096
49. Pietrini P, Alexander GE, Furey ML, Dani A, Mentis MJ, Horwitz B, Guazzelli M, Schapiro MB, Rapoport SI (Submitted) Cerebral metabolic response to passive audiovisual stimulation in Alzheimer's disease patients and healthy controls: A PET "stress test" for dementia
50. Pietrini P, Furey ML, Alexander GE, Mentis MJ, Dani A, Guazzelli M, Rapoport SI, Schapiro MB (1999) Association between brain functional failure and dementia severity in Alzheimer's disease: Resting versus stimulation PET study. Am J Psychiatry 156:470-473
51. Pietrini P, Rapoport SI (1998) Unpublished observation
52. Rapoport SI (1988) Brain evolution and Alzheimer's disease. Rev Neurol (Paris) 144:79-90
53. Rapoport SI (1991) Positron emission tomography in Alzheimer's disease in relation to disease pathogenesis: A critical review. Cerebrovasc Brain Metab Rev 3:297-335
54. Rapoport SI (1997). Deux stades, réversible et irréversible, de l'insuffisance fonctionnelle dans le cerveau Alzheimerien. In: Christien Y (ed) De la Neurophysiologie à la Maladie D'Alzheimer. Symposium en Hommage à Yvon Lamour. Solal, Marseille, pp 165-172
55. Rapoport SI, Grady CL (1993) Parametric in vivo brain imaging during activation to examine pathological mechanisms of functional failure in Alzheimer's disease. Int J Neurosci 70:39-56
56. Rapoport SI, Hatanpää K, Brady DR, Chandrasekaran K (1996) Brain energy metabolism, cognitive function and down-regulated oxidative phosphorylation in Alzheimer's disease. Neurodegeneration 5:473-476
57. Reiman EM, Caselli RJ, Yun LS, Chen K, Bandy D, Minoshima S, Thibodeau SN, Osborne D (1996) Preclinical evidence of Alzheimer's disease in persons homozygous for the e4 allele for apolipoprotein E. N Engl J Med 334:752-758
58. Rogers SL, Friedhoff LT (1998) Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: An interim analysis of the results of a US multicentre open label extension study. Eur Neuropsychopharmacol 8:67-75
59. Scarpulla RC (1996) Nuclear respiratory factors and the pathways of nuclear-mitochondrial interaction. Trends Cardiovasc Med 6:39-45
60. Scheff SW, DeKosky ST, Price DA (1990) Quantitative assessment of cortical synaptic density in Alzheimer's disease. Neurobiol Aging 11:29-37
61. Scheff SW, Sparks DL, Price DA (1996) Quantitative assessment of synaptic density in the outer molecular layer of the hippocampal dentate gyrus in Alzheimer's disease. Dementia 7: 226-232
62. Simpson IA, Chundu KR, Davies-Hill T, Honer WG, Davies P (1994) Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease. Ann Neurol 35:546-551
63. Sims NR, Finegan JM, Blass JP, Bowen DM, Neary D (1987) Mitochondrial function in brain tissue in primary degenerative dementia. Brain Res 436:30-38
64. Small GW, Mazziotta JC, Collins MT, Baxter LR, Phelps ME, Mandelkern MA, Kaplan A, La Rue A, Adamson CF, Chang L, Guze BH, Corder EH, Saunders AM, Haines JL, Pericak-Vance MA, Roses AD (1995) Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer's disease. JAMA 273:942-947
65. Sokoloff L (1991). Relationship between functional activity and energy metabolism in the nervous system: whether, where and why. In: Lassen NA, Ingvar DH, Raichle ME, Friberg L (eds) Brain Work and Mental Activity. Quantitative Studies with Radioactive Tracers. Alfred Benzon Symposium VIII Munksgaard, Copenhagen, Munksgaard pp. 52-67
66. Tamataini M, Chandrasekaran K, Filburn CR (1997) Unpublished observations
67. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R (1991) Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment. Ann Neurol 30:572-580
68. VanMeter JW, Maisog JM, Zeffiro TA, Hallett M, Herscovitch P, Rapoport SI (1995) Parametric analysis of functional neuroimages: application to a variable-rate motor task. Neuroimage 2: 272-383
69. Wallace DC (1999) Mitochondrial diseases in man and mouse. Science 283:1482-1488
70. Wong-Riley MTT (1989) Cytochrome oxidase: an endogenous metabolic marker for neuronal activity. Trends Neuroscience 12:94-101